DanCann Pharma towards commercialisation with rights issue

For DanCann, the aim is clear – to give patients who lack treatment options a better life through medical cannabis and cannabinoids.

After building a solid portfolio of products, the next step for the Danish pharma company is commercialisation. In order to take this step, the company is now conducting a rights issue that, if.